BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 17998148)

  • 21. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
    Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
    Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the major histocompatibility complex loci and T-cell receptor beta-chain repertoire on Theiler's virus-induced demyelinating disease.
    Kim BS; Mohindru M; Kang B; Kang HS; Palma JP
    J Neurosci Res; 2005 Sep; 81(6):846-56. PubMed ID: 16049971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes.
    Dolganiuc A; Paek E; Kodys K; Thomas J; Szabo G
    Gastroenterology; 2008 Dec; 135(6):2119-27. PubMed ID: 18835391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine.
    Cayeux S; Bukarica B; Buschow C; Charo J; Bunse M; Dörken B; Blankenstein T
    Gene Ther; 2007 Oct; 14(20):1481-91. PubMed ID: 17700709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein.
    Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M
    J Immunol; 2009 Nov; 183(10):6561-8. PubMed ID: 19846882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens.
    Lapenta C; Santini SM; Spada M; Donati S; Urbani F; Accapezzato D; Franceschini D; Andreotti M; Barnaba V; Belardelli F
    Eur J Immunol; 2006 Aug; 36(8):2046-60. PubMed ID: 16856207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
    Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
    Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
    Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
    Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel peptide-based vaccines efficiently prime murine "help"-independent CD8+ T cell responses in the liver.
    Dikopoulos N; Riedl P; Schirmbeck R; Reimann J
    Hepatology; 2004 Aug; 40(2):300-9. PubMed ID: 15368434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.
    Castelli FA; Leleu M; Pouvelle-Moratille S; Farci S; Zarour HM; Andrieu M; Auriault C; Ménez A; Georges B; Maillere B
    Eur J Immunol; 2007 Jun; 37(6):1513-23. PubMed ID: 17492804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
    Rigopoulou EI; Abbott WG; Williams R; Naoumov NV
    Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation.
    Waeckerle-Men Y; Starke A; Wahl PR; Wüthrich RP
    Kidney Blood Press Res; 2007; 30(6):421-9. PubMed ID: 17975322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.
    Dembic Z; Schenck K; Bogen B
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2697-702. PubMed ID: 10706628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
    Kleindienst P; Brocker T
    Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients.
    Mancini-Bourgine M; Bayard F; Soussan P; Deng Q; Lone YC; Kremsdorf D; Michel ML
    J Virol; 2007 May; 81(10):4963-72. PubMed ID: 17360751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-4 deficiency does not impair the ability of dendritic cells to initiate CD4+ and CD8+ T cell responses in vivo.
    Roberts JM; Yang J; Ronchese F
    Int Immunol; 2004 Oct; 16(10):1451-8. PubMed ID: 15326095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery.
    Rodríguez T; Pérez O; Ménager N; Ugrinovic S; Bracho G; Mastroeni P
    Vaccine; 2005 Jan; 23(10):1312-21. PubMed ID: 15652674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Priming of CD8+ T cell responses by pathogens typically depends on CD70-mediated interactions with dendritic cells.
    Schildknecht A; Miescher I; Yagita H; van den Broek M
    Eur J Immunol; 2007 Mar; 37(3):716-28. PubMed ID: 17295392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.